Scrip Asia 100: Sales Blown Off Course By Currency Headwinds
This article was originally published in PharmAsia News
Executive Summary
Fiscal 2013 was a difficult year for Asian drug producers. 2013 drug revenues were $128 billion, 5.1% down on 2012 levels ($136 billion) across the 85 publicly-traded pharmaceutical companies that constitute the Scrip Asia 100.